
AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
At close: Oct 28, 2025, 3:47 PM ET
AstraZeneca Cash Flow Statement
Cash flow statement explainedFiscal Quarter Period Ending | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.13B | 2.99B | 1.67B | 1.83B | 1.93B | 2.17B | 985.07M | 1.65B | 2.09B | 2.26B | 778M | 923M | 247M | 553M | -636M | -2B | 764M | 1.61B | 1.17B | 853M | 961M | 935M | |
| 1.39B | 1.32B | 2.34B | 1.82B | 1.28B | 1.25B | 1.36B | 1.28B | 1.28B | 1.5B | 1.48B | 1.33B | 1.36B | 1.31B | 2.19B | 2.79B | 753M | 797M | 797M | 801M | 710M | 841M | |
| – | – | – | – | – | – | 579M | – | – | – | 619M | – | – | – | 615M | – | – | – | 277M | – | – | – | |
| -345M | -436.89M | -350M | 41M | -129M | -455M | -150M | 897M | -989M | 242M | -3.46B | 1.07B | 587M | 1.8B | -2.06B | 1.21B | -353M | 1.21B | 255M | 525M | -335M | -445M | |
| -785M | -157.45M | -746M | -303M | 4.08M | 2.1B | 5.71M | -717M | -657M | -873M | -159M | -394M | -943M | -434M | -96M | -274M | -272M | -1.68B | -782M | -357M | -296M | -1.19B | |
| – | – | – | – | – | – | -579M | – | – | – | -619M | – | – | – | – | – | – | – | – | – | – | – | |
| -345M | -436.89M | -350M | 41M | -129M | -452.97M | 153.39M | 897M | -989M | 242M | 299M | 1.07B | 587M | 1.8B | -42M | 1.21B | -353M | 1.21B | 616M | 525M | -335M | -445M | |
| 3.39B | 3.71B | 2.91B | 3.38B | 3.09B | 2.57B | 2.51B | 3.11B | 1.72B | 3.13B | 2.4B | 2.93B | 1.25B | 3.23B | 1.42B | 1.72B | 892M | 1.93B | 1.8B | 1.82B | 1.04B | 139M | |
| -1.92B | -439.96M | -955M | -1.36B | -671.74M | -1.6B | -964.48M | -879M | -483M | -1.47B | -554M | -1.11B | -543M | -363M | -718M | -660M | -353M | -469M | -548M | -705M | -977M | -376M | |
| -267M | -362M | -274M | -281M | -2.3B | -891.02M | -305.19M | -273M | -184M | -426M | -189M | -342M | -288M | -242M | -218M | -9.63B | -138M | 550M | -159M | -310M | -186M | -175M | |
| -188M | – | – | -29M | 31M | -97.56M | -97.1M | -95M | -26M | -767M | 190M | -321M | -24M | -4M | 6M | -180M | -10M | -55.03M | – | – | -4M | -115M | |
| 114M | 1.03M | -31.6M | 47M | 84M | -39.82M | 99.29M | -68M | 81M | 19M | 182M | -2M | -9M | 53M | -15M | -15M | 107M | 28M | 475M | 239M | 1.13B | 282M | |
| -1.11B | 101.74M | -167.4M | -834M | -306.65M | 74.67M | 88.5M | 94M | 92M | 1.4B | 122M | 33M | 64M | 388M | -726M | -764M | 186M | 197M | 185M | -281M | -1.22B | 406M | |
| -2.11B | -1.25B | -1.18B | -1.51B | -2.87B | -2.49B | -1.18B | -1.22B | -520M | -1.25B | -249M | -1.74B | -800M | -168M | -913M | -10.46B | -236M | 555M | 138M | -580M | 148M | 9M | |
| 632M | 1.12B | -608M | -2.42B | -1.12B | 4.9B | -240.58M | -1.19B | -1.44B | 1.76B | -72M | -52M | -1.24B | -78M | -905M | 1.6B | 7.35B | -194.11M | -1.66B | 2.47B | 1.18B | 176M | |
| – | -498.42M | 817.2M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -10M | -3.43B | -3M | -1.58B | -17M | -3.02B | -4.76M | -1.37B | -24.15M | -3.09B | -97.37M | -1.31B | -93.17M | -2.97B | -14.37M | -1.39B | -17.53M | -2.47B | – | -1.17B | – | -2.4B | |
| -105M | 92.77M | -83M | -59M | -91.31M | 160M | -48.42M | -128.88M | -108.15M | -697.22M | -304M | 12M | -60M | -696M | -131.63M | -68M | -60M | -72.89M | -570M | -58M | -54M | -146M | |
| 518M | -2.71B | -671M | -4.13B | -1.22B | 2.02B | -288.47M | -2.73B | -1.52B | -2.03B | -358M | -1.43B | -1.3B | -3.74B | -1.05B | 142M | 7.29B | -2.73B | -2.21B | 1.24B | 1.13B | -2.36B | |
| 1.83B | -222M | 994M | -2.24B | -1.02B | 2B | 964.15M | -852M | -357M | -155M | 1.8B | -294M | -873M | -685M | -535M | -8.62B | 7.96B | -309M | -248M | 2.49B | 2.33B | -2.25B | |
| 1.46B | 3.44B | 1.95B | 2.03B | 2.53B | 969.66M | 1.54B | 2.24B | 1.24B | 1.66B | 1.84B | 1.82B | 705M | 2.87B | 700M | 1.06B | 539M | 1.47B | 1.25B | 1.12B | 63M | -237M | |
| 1.46B | 3.44B | 1.95B | 2.03B | 2.53B | 969.66M | 962.33M | 2.24B | 1.24B | 1.66B | 1.23B | 1.82B | 705M | 2.87B | 85M | 1.06B | 539M | 1.47B | 973M | 1.12B | 63M | -237M | |
| -1.39B | -439.96M | -289.39M | -817.55M | -268.09M | -1.14B | -648.24M | -736.39M | -302.64M | -1.47B | -554M | -783.68M | – | – | – | – | – | -171.1M | -320.9M | -652.64M | -839.4M | -113.28M | |
| -534M | – | -665.61M | -540.45M | -403.66M | -454.56M | -316.25M | -142.61M | -180.36M | – | – | -327.32M | -543M | -363M | -718M | -660M | -353M | -297.9M | -227.1M | -52.36M | -137.6M | -262.72M | |
| 2B | 3.44B | 2.62B | 2.57B | 2.94B | 1.42B | 1.86B | 2.38B | 1.42B | 1.66B | 1.84B | 2.15B | 1.25B | 3.23B | 1.42B | 1.72B | 892M | 1.76B | 1.48B | 1.17B | 200.6M | 25.72M |
Add to Watchlist
Select watchlists to add or remove AZNCF